Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer
Global women's health executive to lead Arletta in its development strategy focused on advancing Lybrido™'s (sildenafil/testosterone) Phase 2 MONARCH study following positive FDA correspondence Effective September 1, 2026 Over 30 years of…
Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms
The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies including UCB SA, Bridgebio Pharma Inc. and Sun Pharmaceutical Industries Ltd. As part of the deal, the companies will provide discounts…
Donald Trump announces pharma deal: List of drugs getting prices reduced
President Donald Trump on Monday announced agreements with nine additional drug manufacturers as part of his administration's effort to lower prescription drug costs. The agreements are part of the administration's 'Most Favored Nation' (MFN) drug…
PMV Pharma announces proposed public offering (PMVP:NASDAQ)
PMV Pharmaceuticals () said on Monday it launched an underwritten public offering of common stock and accompanying warrants. The company may also offer pre-funded warrants to certain investors in lieu of common stock, along with accompanying…
Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes
Sun Pharmaceutical Industries will extend Most Favoured Nation (MFN) pricing to state medicaid programmes of the U.S. It has also committed to MFN pricing for future innovative medicine launches. The announcement followed a White House ceremony on…
Trump Secures Drug Pricing Deals With Nine Pharma Companies
President Donald Trump announced new drug pricing agreements with nine pharmaceutical companies on Monday, expanding his administration's campaign to lower prescription drug costs for Americans. The agreements involve Astellas, BeOne Medicines…
Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)
Second Quarter 2026 Results: Gross Margin of 90.9% and Category Leadership HERZLIYA, Israel and CALGARY, Alberta, Aug. 31, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ('Innocan' or the 'Company'), today reported today 2026…
Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials
shares rose after the drugmaker reported positive results from two late-stage trials in the most common form of multiple sclerosis, saying its new pill helped patients experience fewer flare-ups. Shares in Novartis were up 4.5% in European midday…
Sun Pharma signs US MFN pricing agreement for Medicaid programmes
India's Sun Pharmaceutical Industries is among nine drugmakers that have signed an agreement with the United States government to extend “Most Favoured Nation” (MFN) pricing in America. The company said it would extend MFN pricing to…
NIO's Loss Narrows on EV Sales Growth
Chinese electric-vehicle maker reported a narrower loss in the second quarter, thanks to robust deliveries and its premium positioning, though the sequential decline in monthly sales weighed on shares. Its net loss came to 721.6 million yuan…
Ascendis Pharma A/S (NASDAQ:ASND) Receives Consensus Rating of 'Buy' from Brokerages
Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) have earned a consensus recommendation of 'Buy' from the twenty ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with…
Stock market today: Dow, S&P 500, Nasdaq futures fall as inflation, Fed rate-hike fears persist
US stock futures meandered on Tuesday morning as uncertainty around the war in Iran, the bond market, and the Fed's next interest rate move largely kept buyers on the sidelines. Futures on the Dow Jones Industrial Average (YM=F) and S&P 500 (ES=F)…
Montanova Capital LLC Takes Position in Avalyn Pharma Inc. $AVLN
Montanova Capital LLC acquired a new stake in shares of Avalyn Pharma Inc. (NASDAQ:AVLN - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired…
Ascendis Pharma A/S (NASDAQ:ASND) Receives 'Outperform' Rating from Wedbush
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report)'s stock had its 'outperform' rating reiterated by investment analysts at Wedbush in a research note issued on Tuesday, Benzinga reports. They presently have a $327.00 price objective on the…
Royalty Pharma (NASDAQ:RPRX) Sets New 52-Week High - What's Next?
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday. The company traded as high as $62.58 and last traded at $62.2280, with a volume of 110214 shares changing hands. The stock had previously…
Receive a Daily briefing on Pharma Industry News
Get Started